Do you or your child experience uncontrolled eosinophilic asthma? DISEASE/SYMPTOMS This study is looking to see whether Dexpramipexole will reduce inflammation and swelling within the respiratory system thereby reducing asthma symptoms. Study drug has already been shown to lower the absolute Eosinophil Count (AEC) and increase forced expiratory volume (FEV). High AEC is associated with… Continue reading Areteia Therapeutics – AR-DEX-22-03 – Dexpramipexole
Studies Category: Respiratory
Areteia Therapeutics – AR-DEX-22-02 – Dexpramipexole
Do you or your child experience uncontrolled severe eosinophilic asthma? DISEASE/SYMPTOMS This study is looking to see whether Dexpramipexole will reduce inflammation and swelling within the respiratory system thereby reducing asthma symptoms. Study drug has already been shown to lower the absolute Eosinophil Count (AEC) and increase forced expiratory volume (FEV). High AEC is associated… Continue reading Areteia Therapeutics – AR-DEX-22-02 – Dexpramipexole
A study of an inhaled anti-inflammatory medication for patients with COPD on Triple Therapy.
Are you struggling with COPD? CLICK HERE FOR MORE INFORMATION: Study Brochure Study Poster The Study A 52-week study to assess the safety of an add-on inhaled medication for subjects with COPD. Study Benefits This medication is designed to reduce inflammation in COPD patients not adequately controlled on triple therapy Free study related care and… Continue reading A study of an inhaled anti-inflammatory medication for patients with COPD on Triple Therapy.